Brand family
Exforge HCT
Amlodipine, Hydrochlorothiazide and Valsartan · Novartis Pharmaceuticals
United States
- Presentations
- 5
- Markets
- 1
Exforge HCT is a brand of Amlodipine, Hydrochlorothiazide and Valsartan marketed by Novartis Pharmaceuticals, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Amlodipine, Hydrochlorothiazide and Valsartan
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 10 mg/12.5 mg/160 mg tablet, 10 mg/25 mg/160 mg tablet, 10 mg/25 mg/320 mg tablet, 5 mg/12.5 mg/160 mg tablet, 5 mg/25 mg/160 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Exforge HCT 10 mg/12.5 mg/160 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Exforge HCT 10 mg/25 mg/160 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Exforge HCT 10 mg/25 mg/320 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Exforge HCT 5 mg/12.5 mg/160 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Exforge HCT 5 mg/25 mg/160 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Exforge HCT
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.